GABRIEL ALVAREZ: Open Payments
NPI 1144576190 · LONGWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,680 in 69 payments from 16 companies in 2025. Trend: 2023 $25,439 · 2024 $649 · 2025 $1,680
Food & beverage: $1,680
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 18 | $524 |
| Otsuka America Pharmaceutical, Inc. | 6 | $214 |
| ABBVIE INC. | 7 | $183 |
| Collegium Pharmaceutical, Inc. | 6 | $177 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $85 |
| Neos Therapeutics, LP | 4 | $75 |
| Bausch Health US, LLC | 4 | $72 |
| Corium, LLC | 4 | $67 |
| Vanda Pharmaceuticals Inc. | 3 | $64 |
| Alkermes, Inc. | 3 | $50 |
Products named: Auvelity, REXULTI, VRAYLAR, Jornay PM, ABILIFY ASIMTUFII, CAPLYTA, Adzenys XR-ODT, APLENZIN.
Industry payments across FL — which companies pay providers there.
